DATE |
TITLE |
|
| August 16, 2011 | POZEN Welcomes Clint Burrus as Vice President, Customer Development |  |
| August 08, 2011 | Pozen Patents Upheld in Treximet Patent Litigation | |
| July 28, 2011 | POZEN Reports Second Quarter 2011 Results | |
| July 27, 2011 | POZEN Welcomes Dr. Seth A. Rudnick to the Board of Directors | |
| July 19, 2011 | POZEN Forms Unprecedented Advisory Board of Digital Thought-Leaders to Advance Commercial Plans | |
| July 14, 2011 | POZEN Announces July 28, 2011 Webcast of Second Quarter 2011 Results | |
| June 16, 2011 | POZEN Announces Election of Dr. Martin Nicklasson to the Board of Directors | |
| June 15, 2011 | POZEN to Present at The UBS Specialty Pharmaceuticals Conference | |
| June 09, 2011 | POZEN to Present at the 2011 Wells Fargo Securities Healthcare Conference | |
| May 25, 2011 | POZEN Ranked as Second Most Efficient Pharma Company by SmarTrend | |
| May 24, 2011 | POZEN to Present at the Jefferies 2011 Global Life Sciences Conference | |
| May 05, 2011 | POZEN Reports First Quarter 2011 Results | |
| April 25, 2011 | AstraZeneca and POZEN File Patent Infringement Lawsuit Against Dr. Reddy’s | |
| April 21, 2011 | POZEN Announces May 5, 2011 Webcast of First Quarter 2011 Results | |
| April 15, 2011 | Preliminary Injunction Ordered in POZEN Treximet Patent Litigation | |
| March 24, 2011 | POZEN To Present at the 10th Annual Needham Healthcare Conference | |
| March 24, 2011 | POZEN Reports Superior Platelet Inhibition of PA32540 Regimen Over a Standard of Care Regimen in a Phase 1 Study (“Co-Rx”) | |
| March 23, 2011 | POZEN Announces Licensing Deal with Cilag GmbH, A Division of Johnson & Johnson, for MT 400, Migraine Treatment | |
| March 22, 2011 | POZEN Files Motion for Preliminary Injunction in Treximet Patent Litigation | |
| March 09, 2011 | POZEN Reports Fourth Quarter and Year End 2010 Results | |
| February 24, 2011 | POZEN Announces March 9, 2011 Webcast of Fourth Quarter & Year End 2010 Results | |
| February 23, 2011 | POZEN to Present at the Cowen and Company 31st Annual Healthcare Conference | |
| February 22, 2011 | POZEN Announces Addition to Commercial Team | |
As a next generation pharmaceutical company, to say things change fast around here is an understatement. Whether it’s robust results from one of our clinical trials or a newfound strategic partnership that has inspiring possibilities, new developments abound. And since keeping our stake holders informed is a priority, we’ll keep you up-to-date with news and exciting breakthroughs.